Physician profile
Stacey Strunk
NPI 1174141477
$1,403.60
in general payments reported to CMS, 2019-2025
16 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $350 · 2022: $777 · 2023: $18.73 · 2024: $24.63 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $524.95 | 2022 | |
| Abbvie INC. | $358.68 | 2021-2023 | |
| Inspire Medical Systems, INC. | $100.00 | 2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $98.25 | 2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.62 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.65 | 2021 | |
| Gilead Sciences, INC. | $44.54 | 2022 | |
| Merck Sharp & Dohme LLC | $27.63 | 2025 | Keytruda Qlex, Keytruda |
| Myriad Genetic Laboratories, INC. | $24.63 | 2024 | Myrisk |
| Alkermes, INC. | $20.44 | 2022 | |
| Celgene Corporation | $19.06 | 2021 | |
| Janssen Biotech, INC. | $17.97 | 2021 | |
| Redhill Biopharma INC. | $14.55 | 2021 | |
| Medtronic, INC. | $13.90 | 2021 | |
| Mylan Specialty L.P. | $13.38 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $7.35 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Strunk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.